211 related articles for article (PubMed ID: 22019959)
21. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
22. The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy.
Vermoesen K; Massie A; Smolders I; Clinckers R
Epilepsia; 2012 May; 53(5):870-8. PubMed ID: 22429158
[TBL] [Abstract][Full Text] [Related]
23. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy.
Falenski KW; Blair RE; Sim-Selley LJ; Martin BR; DeLorenzo RJ
Neuroscience; 2007 May; 146(3):1232-44. PubMed ID: 17433556
[TBL] [Abstract][Full Text] [Related]
24. AIT-082 is neuroprotective against kainate-induced neuronal injury in rats.
Di Iorio P; Virgilio A; Giuliani P; Ballerini P; Vianale G; Middlemiss PJ; Rathbone MP; Ciccarelli R
Exp Neurol; 2001 Jun; 169(2):392-9. PubMed ID: 11358452
[TBL] [Abstract][Full Text] [Related]
25. Drug-drug interactions between antiepileptics and cannabinoids.
Miziak B; Walczak A; Szponar J; Pluta R; Czuczwar SJ
Expert Opin Drug Metab Toxicol; 2019 May; 15(5):407-415. PubMed ID: 30991855
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia.
Martínez-Orgado J; Fernández-Frutos B; González R; Romero E; Urigüen L; Romero J; Viveros MP
Brain Res Mol Brain Res; 2003 Jun; 114(2):132-9. PubMed ID: 12829323
[TBL] [Abstract][Full Text] [Related]
27. [Protective effects of CB1 receptor agonist WIN 55.212-2 in seizure activity in the model of temporal lobe epilepsy].
Shubina LV; Kichigina VF
Zh Vyssh Nerv Deiat Im I P Pavlova; 2011; 61(1):94-101. PubMed ID: 21469332
[TBL] [Abstract][Full Text] [Related]
28. Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies.
Zheng Y; Moussally J; Cash SS; Karnam HB; Cole AJ
Neuropharmacology; 2010; 58(4-5):793-8. PubMed ID: 20026136
[TBL] [Abstract][Full Text] [Related]
29. Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Florek-Luszczki M; Wlaz A; Zagaja M; Andres-Mach M; Kondrat-Wrobel MW; Luszczki JJ
Pharmacol Biochem Behav; 2015 Mar; 130():53-8. PubMed ID: 25592741
[TBL] [Abstract][Full Text] [Related]
30. Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2.
Payandemehr B; Ebrahimi A; Gholizadeh R; Rahimian R; Varastehmoradi B; Gooshe M; Aghaei HN; Mousavizadeh K; Dehpour AR
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():140-5. PubMed ID: 25448777
[TBL] [Abstract][Full Text] [Related]
31. Early endocannabinoid system activation attenuates behavioral impairments induced by initial impact but does not prevent epileptogenesis in lithium-pilocarpine status epilepticus model.
Suleymanova EM; Borisova MA; Vinogradova LV
Epilepsy Behav; 2019 Mar; 92():71-78. PubMed ID: 30634156
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V
Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057
[TBL] [Abstract][Full Text] [Related]
33. WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids.
Barna I; Soproni K; Arszovszki A; Csabai K; Haller J
Behav Pharmacol; 2007 Sep; 18(5-6):515-20. PubMed ID: 17762520
[TBL] [Abstract][Full Text] [Related]
34. Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus.
Yim TT; Hong NS; Ejaredar M; McKenna JE; McDonald RJ
Neuroscience; 2008 Feb; 151(4):929-36. PubMed ID: 18248907
[TBL] [Abstract][Full Text] [Related]
35. GluR2(B) knockdown accelerates CA3 injury after kainate seizures.
Friedman LK; Velísková J; Kaur J; Magrys BW; Liu H
J Neuropathol Exp Neurol; 2003 Jul; 62(7):733-50. PubMed ID: 12901700
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Neuroscience; 2015 Sep; 303():149-59. PubMed ID: 26135674
[TBL] [Abstract][Full Text] [Related]
38. Topiramate reduces neuronal injury after experimental status epilepticus.
Niebauer M; Gruenthal M
Brain Res; 1999 Aug; 837(1-2):263-9. PubMed ID: 10434011
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
[TBL] [Abstract][Full Text] [Related]
40. (+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters.
Richter A; Löscher W
Eur J Pharmacol; 1994 Nov; 264(3):371-7. PubMed ID: 7698178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
